TR 700

Known as: TR-700 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2012
02420082012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
OBJECTIVES To compare the activity of tedizolid (formally known as torezolid and TR-700) with that of 15 agents against a… (More)
  • table 1
  • table 2
Is this relevant?
2012
2012
Tedizolid (TR-700, formerly torezolid) is the active moiety of the prodrug tedizolid phosphate (TR-701), a next-generation… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2011
2011
Torezolid phosphate (TR-701) is the phosphate monoester prodrug of the oxazolidinone TR-700 which demonstrates potent in vitro… (More)
Is this relevant?
2010
2010
This study assessed the spectrum of activity of torezolid (TR-700), the active moiety of torezolid phosphate (TR-701), and… (More)
Is this relevant?
2010
2010
The in vitro activity of TR-700 (torezolid) was evaluated against a collection of 660 staphylococcal blood isolates. TR-700… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
TR-700 (torezolid), the active moiety of the novel oxazolidinone phosphate prodrug TR-701, is highly potent against gram-positive… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
TR-701 is the prodrug of the microbiologically active molecule TR-700, a novel orally and intravenously administered… (More)
Is this relevant?
2009
2009
BACKGROUND TR-700, the active component of the oxazolidinone prodrug TR-701, has demonstrated potent activity against numerous… (More)
Is this relevant?
2009
2009
BACKGROUND AND AIMS Optimal treatment of infections caused by Staphylococcus aureus, Listeria monocytogenes and Legionella… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
TR-701 is the orally active prodrug of TR-700, a novel oxazolidinone that demonstrates four- to eightfold-greater activity than… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?